July 25, 2016 12:50 - 2:05 pm
Advances in the techniques of gene editing have produced a flurry of concern about who is in charge of controlling technologies that may affect the human germline. It is widely accepted in international legal, regulatory, and ethical frameworks that the human genome is the common property of human kind, and as such not subject to manipulation or appropriation by interested economic or political actors. As yet, however, it remains unclear how the fundamental principle of common ownership can or will translate into effective forms of democratic governance at the global scale. Reviewing existing transnational frameworks on bioethics and human rights, this talk will lay out the institutional challenges, and opportunities, for democratizing the global governance of gene editing.